Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Novo Nordisk inflammation-targeting drug misses mark in heart disease study
40+ min ago (170+ words) Novo Nordisk said Friday that its investigational anti-inflammatory drug did not reduce the risk of major heart events in a pivotal trial, raising questions about the increasingly popular approach of targeting inflammation to prevent cardiovascular complications. In a Phase 3 study…...
What a recent op-ed got wrong about our Covid study
4+ hour, 43+ min ago (506+ words) By Thomas J. Bollyky and Joseph Dieleman First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues…...
Capricor's data clash and a fugitive in the C-suite
18+ hour, 11+ min ago (276+ words) Is the Food and Drug Administration taking inconsistent approaches to Duchenne muscular dystrophy drugs? How will a new batch of drug executives shake up their companies? And why is Adam talking to a recruiter? We discuss all that and more…...
Why benchmarking clinical LLMs from OpenEvidence, Doximity is complicated
1+ day, 23+ hour ago (258+ words) I saw “The Odyssey” during its opening weekend. Ever since then, I have been questioning whether I’m illiterate or whether Christopher Nolan is a poor storyteller. This London Review of Books evaluation of the film, written by the woman whose…...
Can doctors trust clinical AI? The complicated issue of LLM benchmarks
2+ day, 4+ hour ago (175+ words) Clinical chatbots are taking medicine by storm. Should doctors trust them? STAT Clinical chatbots are taking medicine by storm. Should doctors trust them? What benchmarks do — and don’t — say about clinical LLMs from OpenEvidence, Doximity, and UpToDate Katie covers the…...
The VA could help America win the biotechnology race with China
2+ day, 4+ hour ago (246+ words) Biotechnology is rapidly becoming a pillar of national power. The nation that can discover, test, and deploy new therapies most efficiently will not only improve the health of its citizens but also shape global standards, attract investment, strengthen military readiness,…...
Visa time limits on foreign Ph.D. students and postdocs will harm U.S. science, experts warn
2+ day, 20+ hour ago (243+ words) For nearly half a century, the federal government encouraged international students and scholars to study in the U.S. by allowing them to stay for the duration of their training — regardless of how many years it took. The Trump administration now plans…...
Three questions with Whoop's new CMO
2+ day, 23+ hour ago (140+ words) STAT is a media company focused on finding and telling compelling stories about health, medicine, and scientific discovery. We produce daily news, investigative articles, and narrative projects in addition to multimedia features, podcasts, and opinion pieces. We tell our stories…...
Preliminary trial results suggest a path to a safer Alzheimer's treatment
3+ day, 3+ hour ago (242+ words) Adam Feuerstein is a senior writer and biotech columnist for STAT, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a cohost of STAT's weekly "The Readout LOUD" podcast and the author of the…...
How a single rare disease, AATD, sparked a biotech gold rush
3+ day, 4+ hour ago (1798+ words) Rarely has a new technology so squarely lent itself to one disease. Here’s why. Major biotechs, including Beam, Wave Life Sciences, Korro Bio, Tessera, and Yoltech are targeting a single misspelled letter of DNA. Biotechs are spending billions to cure…...